J. Wolter Oosterhuis

POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.

Leendert H. J. Looijenga, Hans Stoop, Hubert P. J. C. de Leeuw et al. · PubMed · 2003 · 646 citations

Embryology, Developmental Biology, Germ Cell +15

Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study

M. van Glabbeke, A.T. van Oosterom, J. Wolter Oosterhuis et al. · Journal of Clinical Oncology · 1999 · 565 citations

A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma

E. Gortzak, Alberto Azzarelli, J. Buesa et al. · European Journal of Cancer · 2001 · 376 citations

Surgical Oncology, Malignant Disease, Medicine +7

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

J. Beyer, Peter Albers, Renske Altena et al. · Annals of Oncology · 2012 · 320 citations · Full text

Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis

N.E. Verstegen, J. Wolter Oosterhuis, David A. Palma et al. · Annals of Oncology · 2013 · 271 citations · Full text

Propensity Score-matched Analysis, Video-assisted Thoracoscopic Surgery, Surgical Oncology +10